Tilray Brands Posts Record Q1 Revenue and Gross Profit in Fiscal 2027

Tilray Brands achieved record revenue and gross profit in the first quarter of fiscal 2027, the company announced, citing double-digit year-over-year gains across three of its core business segments: international cannabis, beverage, and pharmaceutical distribution.

The results underscore what Tilray's leadership described as the strength of its global operating platform, with disciplined cost management and category leadership combining to lift both top-line sales and margin performance simultaneously — an outcome the company has been working toward as it integrates a series of acquisitions made in recent years.

Read more CME Group to Launch First-Ever Baseball Futures Contracts Oct. 12 →

International cannabis continued to emerge as a key growth engine for the company, reflecting expanding legal markets in Europe and other regions where Tilray has established distribution footholds. The beverage segment, which grew significantly after Tilray acquired several craft beer brands, also contributed meaningfully to the record quarter alongside the pharmaceutical distribution business.

Analysts tracking the cannabis sector have noted that Tilray's diversified revenue model — spanning regulated cannabis, consumer beverages, and pharmaceutical logistics — positions it differently from pure-play cannabis operators, providing more stable cash flows even as domestic North American cannabis markets face ongoing pricing and regulatory pressures.

The first-quarter performance signals continued momentum as Tilray works to convert its global scale into sustained profitability, a benchmark that has remained elusive across much of the cannabis industry. Continue reading at GlobeNewswire - Earnings Releases And Operating Results.